THE EXPERIENCE OF SWITCHING TO THE SECOND TNF INHIBITOR IN A PATIENT WITH SEVERE JUVENILE POLYARTHRITIS AND RESISTANCE TO THE FIRST TNF-BLOCKER

THE EXPERIENCE OF SWITCHING TO THE SECOND TNF INHIBITOR IN A PATIENT WITH SEVERE JUVENILE POLYARTHRITIS AND RESISTANCE TO THE FIRST TNF-BLOCKER

The article presents  a case  of a severe  progressive  course  of polyarticular  juvenile idiopathic arthritis,  debuting  at an early age, refractory to the therapy with methotrexate, cyclosporine, and glucocorticosteroids.  A clinical example demonstrates that switching to the second TNF  inhibit...

Full description

Bibliographic Details
Main Authors: Ekaterina I. Alexeeva, Tatiana M. Dvoryakovskaya, Rina V. Denisova, Olga L. Lomakina, Anna V. Karaseva
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2017-09-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
children
juvenile idiopathic arthritis
genetically engineered biological preparations
adalimumab
etanercept
Online Access:https://vsp.spr-journal.ru/jour/article/view/1790

Internet

https://vsp.spr-journal.ru/jour/article/view/1790

Similar Items